Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Sales (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Return on Sales for 7 consecutive years, with 0.07% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 12.0% to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07% through Dec 2025, up 3.0% year-over-year, with the annual reading at 0.06% for FY2025, 4.0% up from the prior year.
  • Return on Sales hit 0.07% in Q4 2025 for Eton Pharmaceuticals, up from 0.09% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.43% in Q1 2021 to a low of 7.86% in Q3 2021.
  • Historically, Return on Sales has averaged 0.66% across 5 years, with a median of 0.09% in 2025.
  • Biggest YoY gain for Return on Sales was 23584bps in 2021; the steepest drop was -256216bps in 2021.
  • Year by year, Return on Sales stood at 0.17% in 2021, then tumbled by -37bps to 0.11% in 2022, then crashed by -171bps to 0.08% in 2023, then surged by 32bps to 0.05% in 2024, then skyrocketed by 236bps to 0.07% in 2025.
  • Business Quant data shows Return on Sales for ETON at 0.07% in Q4 2025, 0.09% in Q3 2025, and 0.14% in Q2 2025.